SMAC mimetics overcome apoptotic resistance in ovarian cancer through MSLN-TNF alpha axis
R. Coelho, B. Seashore-Ludlow, S. Schutz, F. Christopher Lombardo, E. Moussaud-Lamodiere, R. Casanova, J. Ficek-Pascual, K. Brunhilde Labrosse, M. Hensle, M. Lopez-Nunez, N. Rimmer, A. Fedier, R. Lima, C. Montavon Sartorius, C. Kurzeder, , F. Jacob
This study shows SMAC mimetics overcome apoptotic resistance in ovarian cancer by targeting the MSLN-TNF alpha axis, enhancing cell death and synergizing with chemotherapy.
bioRxiv · Jan 24, 2024 · PreprintCancer Biology